Biosion, Inc. Raises ¥200M RMB Financing to Support Further Global Development of Its Innovative Pipeline New funding will drive advancement of a global therapeutic portfolio in immunology and oncology, including anti-TSLP and anti-CD40 mAb therapeutics

2020-12-10

View details

Biosion and ZhenGe Biotech Sign Global Strategic Partnership Agreement Accelerating Biosion’s Innovative Antibody Pipeline for IND Filing NEWARK, Delaware, USA and NANJING, China, April 9,2020– Biosion Inc. and Shanghai ZhenGe Biotechnology Co. Ltd. jointly announced today that the two parties have signed a global strategic partnership

2020-04-11

View details

Biosion, Inc. Appoints Hugh Davis, Ph.D., Chief Operating Officer and President of Biosion USA, Inc. Biosion,Inc.AppointsHughDavis,Ph.D.,ChiefOperatingOfficerandPresidentofBiosionUSA,Inc.NEWARK,Delaware,andNANJING,China. March23,2020–BiosionInc.,announcedtheappointmentofHughM.Davis,Ph.D.,asChiefOpera

2020-03-23

View details

Biosynergics, Inc. Completes Series A Financing and Company Restructuring On October 29, 2017, Biosynergics, Inc. ("Biosynergics"), a China-based startup biotech company, announced that it has completed a 30 million RMB Series A financing.

2017-10-29

View details